Company: HRTX
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-060882
Chunk: 58

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 58
---
---|----------:|:----|:------------------|:---------|:--|---:|:----|:------------------|----------:|:----|---:|:----------------------|----------:|:----|---:|
| 2024 |     | $                  | 1,480,471 |     | $                 | (603,336 | ) |    |     | $                 |   794,516 |     |    | $                     | 1,671,651 |     |    |
| 2023 |     | $                  | 1,623,453 |     | $                 | (833,743 | ) | -8 |     | $                 | 1,004,981 |     | -8 | $                     | 1,794,691 |     | -8 |

• The fair value or change in fair value, as applicable, of equity awards was determined by reference to (x) for RSU awards, the closing price of our common stock on the applicable measurement date, (y) for market-conditioned performance-based equity awards, a Monte Carlo simulation with reference to the risk free rate, dividend yield and volatility assumptions as of the applicable measurement date and (z) for options, the closing stock price, in addition to the stock option’s strike price, expected life, volatility, expected dividend yield, and risk-free rate as of the measurement date. The amounts deducted or added in calculating the total average equity award adjustments are as follows:

41

| Year 
 2024 |     | Average Year End Fair Value of Equity Awards Granted in the Year ($) |   420,813 |     |    | Year Over Year Average Change in Fair Value of Outstanding and Unvested Equity Awards at Year End Granted in Prior Years ($) | (224,906 | ) |     | Average Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year ($) | 204,263 |     | Average Change in Fair Value (from the end of the prior year) of Equity Awards Granted in Prior Years that Vested in the Year ($) | 394,346  |   |    | Average Fair Value at the end of the prior year of Equity Awards Granted in Prior Years that Failed to Meet Vesting Conditions in the covered year | —        |   |    | Average Value of Dividends or other Earnings Paid on Stock Awards not Otherwise Reflected in Fair Value or Total Compensation in the Summary Compensation Table for the Fiscal